Skip to main content

Building Resilient Pharmaceutical Supply Chains

A. Duie Pyle

A. Duie Pyle’s Shawn McGee was recently featured in a Q&A with Pharmaceutical Commerce discussing how pharmaceutical supply chains can build greater resilience in an increasingly complex and high-risk environment. The conversation explores key challenges facing the industry today, including temperature control, limited shipment visibility, and the growing complexity of final-mile delivery.

The article highlights how traditional logistics models are being re-evaluated as pharmaceutical manufacturers and distributors look for more reliable ways to move critical, temperature-sensitive freight. As supply chains become more time-sensitive and compliance-driven, the ability to maintain consistent conditions and clear visibility throughout transit has become essential.

McGee emphasizes that resilience is not just about responding to disruptions, but about designing supply chains that reduce risk from the start. This includes minimizing handoffs, improving accountability across the network, and ensuring freight remains within a controlled transportation environment from pickup through delivery. These strategies help protect product integrity while improving overall speed and reliability.

At A. Duie Pyle, this approach is reflected in a direct, asset-based network that prioritizes control and consistency for healthcare and pharmaceutical shipments. By reducing variability and maintaining end-to-end accountability, Pyle supports customers moving sensitive freight with greater confidence.

As the pharmaceutical industry continues to evolve, supply chain design will play a critical role in ensuring products reach patients safely and on time.

Read the full Pharmaceutical Commerce Q&A here.